4C Medical

Maple Grove, MN · Founded 2015 · Privately Held (backing)

Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation. 4C Medical is based in Maple Grove, MN and was founded in 2015. Its last reported valuation was $187 million in Nov 2021. It has raised $165 million across 6 recorded rounds; the latest was a $71.6 million later-stage round in Mar 2025.

Last reported valuation
$187.1M
Oct 2026
Priced at
—
Total raised
$165.1M
Last round
Later Stage VC
Mar 2025

4C Medical key facts

as of Oct 2026
  • Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation.
  • 4C Medical is valued at approximately $187.1M as of Oct 2026 (last reported valuation).
  • It has raised $165.1M across 6 recorded rounds; the latest was Later Stage VC ($71.6M) in Mar 2025.
  • Notable investors include Yonghua Capital, Grant Park Ventures, AG Collective Capital, Anges Québec, Boston Scientific — 8 tracked in total.
  • 4C Medical has filed 8 Form Ds with the SEC since 2016, most recently Mar 2025 ($71.6M sold to 80 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$187.1M

4C Medical's last reported valuation, Nov 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of 4C Medical with a free account
  • ·Watch 4C Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

4C Medical funding rounds

6 rounds
Mar 2025Later Stage VC$71.6MSEC filing▮
Nov 2021Early Stage VC$35.3MSEC filing▮
May 2020Debt$10.0MSEC filing▮
Sep 2019Early Stage VC$8.2MSEC filing▮
Sep 2018Early Stage VC$17.3MSEC filing▮

4C Medical valuation

4C Medical's last reported valuation was $187 million in Nov 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has 4C Medical raised?

4C Medical has raised $165 million across 6 recorded rounds since 2018. The largest was an $8.2 million early-stage round in Sep 2019; the most recent was a $71.6 million later-stage round in Mar 2025.

4C Medical has filed 8 Form Ds with the SEC since 2016, most recently in Mar 2025 ($71.6 million sold to 80 investors).

4C Medical investors

8 investors are on record for 4C Medical, including Yonghua Capital, Grant Park Ventures, AG Collective Capital and Anges Québec. The later-stage round in Mar 2025 drew 80 investors.

About 4C Medical

Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation. The company's system directly addresses the complication without replacing the native mitral valve to preserve the native mitral annulus and left ventricle, enabling doctors to help patients get access to a minimally invasive alternative for the treatment of such complex conditions.

Sector
Healthcare
HQ
Maple Grove, MN, United States
Founded
2015
Employees
55
Website
4cmed.com/
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.